Alin O. Stirban

Birkenwerder, BB, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal.

Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal.

Journal: Diabetology & metabolic syndrome

Published: May 13, 2026

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes.

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes.

Journal: Cardiovascular diabetology

Published: February 18, 2025

Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.

Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.

Journal: Diabetes research and clinical practice

Published: June 28, 2021

Advances in the management of diabetic neuropathy.

Advances in the management of diabetic neuropathy.

Journal: Minerva medica

Published: May 26, 2017

A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes.

A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes.

Journal: Cardiovascular diabetology

Published: July 22, 2016

Effects of dextromethorphan as add-on to sitagliptin on blood glucose and serum insulin concentrations in individuals with type 2 diabetes mellitus: a randomized, placebo-controlled, double-blinded, multiple crossover, single-dose clinical trial.

Effects of dextromethorphan as add-on to sitagliptin on blood glucose and serum insulin concentrations in individuals with type 2 diabetes mellitus: a randomized, placebo-controlled, double-blinded, multiple crossover, single-dose clinical trial.

Journal: Diabetes, obesity & metabolism

Published: August 18, 2015

Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial.

Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial.

Journal: Diabetes, obesity & metabolism

Published: July 03, 2015

Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.

Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.

Journal: Nature medicine

Published: October 29, 2014

Vascular Effects of Dietary Advanced Glycation End Products.

Vascular Effects of Dietary Advanced Glycation End Products.

Journal: International journal of endocrinology

Published: September 09, 2014

Microvascular dysfunction in the context of diabetic neuropathy.

Microvascular dysfunction in the context of diabetic neuropathy.

Journal: Current diabetes reports

Published: September 06, 2014

Measurement of Lens Autofluorescence for Diabetes Screening.

Measurement of Lens Autofluorescence for Diabetes Screening.

Journal: Journal of diabetes science and technology

Published: May 31, 2014

Skin Autofluorescence - A Non-invasive Measurement for Assessing Cardiovascular Risk and Risk of Diabetes.

Skin Autofluorescence - A Non-invasive Measurement for Assessing Cardiovascular Risk and Risk of Diabetes.

Journal: European endocrinology

Published: March 17, 2014

Showing 1-12 of 22

Last Updated: 09/26/2026